Literature DB >> 26474349

Mycobacterium paratuberculosis as a cause of Crohn's disease.

Adrienne L McNees1, Diane Markesich2, Najah R Zayyani3, David Y Graham4.   

Abstract

Crohn's disease is a chronic inflammatory bowel disease of unknown cause, affecting approximately 1.4 million North American people. Due to the similarities between Crohn's disease and Johne's disease, a chronic enteritis in ruminant animals caused by Mycobacterium avium paratuberculosis (MAP) infection, MAP has long been considered to be a potential cause of Crohn's disease. MAP is an obligate intracellular pathogen that cannot replicate outside of animal hosts. MAP is widespread in dairy cattle and because of environmental contamination and resistance to pasteurization and chlorination, humans are frequently exposed through contamination of food and water. MAP can be cultured from the peripheral mononuclear cells from 50-100% of patients with Crohn's disease, and less frequently from healthy individuals. Association does not prove causation. We discuss the current data regarding MAP as a potential cause of Crohn's disease and outline what data will be required to firmly prove or disprove the hypothesis.

Entities:  

Keywords:  Crohn’s disease; Helicobacter pylori; Inflammatory bowel disease; Johne’s disease; Mycobacterium avium subspecies paratuberculosis; prevention; treatment trials

Mesh:

Substances:

Year:  2015        PMID: 26474349      PMCID: PMC4894645          DOI: 10.1586/17474124.2015.1093931

Source DB:  PubMed          Journal:  Expert Rev Gastroenterol Hepatol        ISSN: 1747-4124            Impact factor:   3.869


  111 in total

Review 1.  Immunology of mycobacterial infections: with special reference to Mycobacterium avium subspecies paratuberculosis.

Authors:  Jagdeep Singh Sohal; S V Singh; P Tyagi; Swati Subhodh; P K Singh; A V Singh; K Narayanasamy; Neelam Sheoran; Komal Singh Sandhu
Journal:  Immunobiology       Date:  2008-03-04       Impact factor: 3.144

2.  Genetic variants of SLC11A1 are associated with both autoimmune and infectious diseases: systematic review and meta-analysis.

Authors:  N S Archer; N T Nassif; B A O'Brien
Journal:  Genes Immun       Date:  2015-04-09       Impact factor: 2.676

Review 3.  Crohn's disease and Mycobacterium avium subsp. paratuberculosis: the need for a study is long overdue.

Authors:  William C Davis; Sally A Madsen-Bouterse
Journal:  Vet Immunol Immunopathol       Date:  2011-12-14       Impact factor: 2.046

4.  High prevalence of viable Mycobacterium avium subspecies paratuberculosis in Crohn's disease.

Authors:  Juan L Mendoza; Amparo San-Pedro; Esther Culebras; Raquel Cíes; Carlos Taxonera; Raquel Lana; Elena Urcelay; Fernando de la Torre; Juan J Picazo; Manuel Díaz-Rubio
Journal:  World J Gastroenterol       Date:  2010-09-28       Impact factor: 5.742

5.  Incidence of Mycobacterium paratuberculosis in bulk raw and commercially pasteurized cows' milk from approved dairy processing establishments in the United Kingdom.

Authors:  Irene R Grant; Hywel J Ball; Michael T Rowe
Journal:  Appl Environ Microbiol       Date:  2002-05       Impact factor: 4.792

Review 6.  Mycobacterium avium subspecies paratuberculosis and Crohn's disease: a systematic review and meta-analysis.

Authors:  Martin Feller; Karin Huwiler; Roger Stephan; Ekkehardt Altpeter; Aijing Shang; Hansjakob Furrer; Gaby E Pfyffer; Thomas Jemmi; Andreas Baumgartner; Matthias Egger
Journal:  Lancet Infect Dis       Date:  2007-09       Impact factor: 25.071

Review 7.  Contamination of food products with Mycobacterium avium paratuberculosis: a systematic review.

Authors:  M M Eltholth; V R Marsh; S Van Winden; F J Guitian
Journal:  J Appl Microbiol       Date:  2009-03-30       Impact factor: 3.772

Review 8.  Long-term antibiotic treatment for Crohn's disease: systematic review and meta-analysis of placebo-controlled trials.

Authors:  Martin Feller; Karin Huwiler; Alain Schoepfer; Aijing Shang; Hansjakob Furrer; Matthias Egger
Journal:  Clin Infect Dis       Date:  2010-02-15       Impact factor: 9.079

9.  Metabolomic profiling in cattle experimentally infected with Mycobacterium avium subsp. paratuberculosis.

Authors:  Jeroen De Buck; Rustem Shaykhutdinov; Herman W Barkema; Hans J Vogel
Journal:  PLoS One       Date:  2014-11-05       Impact factor: 3.240

10.  Isolation of Mycobacterium avium subspecies paratuberculosis reactive CD4 T cells from intestinal biopsies of Crohn's disease patients.

Authors:  Ingrid Olsen; Stig Tollefsen; Claus Aagaard; Liv J Reitan; John P Bannantine; Peter Andersen; Ludvig M Sollid; Knut E A Lundin
Journal:  PLoS One       Date:  2009-05-22       Impact factor: 3.240

View more
  39 in total

Review 1.  The intestinal microbiome, barrier function, and immune system in inflammatory bowel disease: a tripartite pathophysiological circuit with implications for new therapeutic directions.

Authors:  Stephen M Vindigni; Timothy L Zisman; David L Suskind; Christopher J Damman
Journal:  Therap Adv Gastroenterol       Date:  2016-04-19       Impact factor: 4.409

2.  Evolutionary genomic and bacteria GWAS analysis of Mycobacterium avium subsp. paratuberculosis and dairy cattle Johne's disease phenotypes.

Authors:  Vincent P Richards; Annette Nigsch; Paulina Pavinski Bitar; Qi Sun; Tod Stuber; Kristina Ceres; Rebecca L Smith; Suelee Robbe Austerman; Ynte Schukken; Yrjo T Grohn; Michael J Stanhope
Journal:  Appl Environ Microbiol       Date:  2021-02-05       Impact factor: 4.792

Review 3.  Challenges in IBD Research: Environmental Triggers.

Authors:  Shuk-Mei Ho; James D Lewis; Emeran A Mayer; Scott E Plevy; Emil Chuang; Stephen M Rappaport; Kenneth Croitoru; Joshua R Korzenik; Jeffrey Krischer; Jeffrey S Hyams; Richard Judson; Manolis Kellis; Michael Jerrett; Gary W Miller; Melanie L Grant; Nataly Shtraizent; Gerard Honig; Andrés Hurtado-Lorenzo; Gary D Wu
Journal:  Inflamm Bowel Dis       Date:  2019-05-16       Impact factor: 5.325

4.  Anti-Mycobacterium paratuberculosis (MAP) therapy for Crohn's disease: an overview and update.

Authors:  Sailish Honap; Emma Johnston; Gaurav Agrawal; Bahij Al-Hakim; John Hermon-Taylor; Jeremy Sanderson
Journal:  Frontline Gastroenterol       Date:  2020-07-28

5.  Antibacterial and Immunosuppressive Effects of OPS-2071, a Candidate Therapy for Inflammatory Bowel Disease.

Authors:  Masayoshi Sato; Kazuyuki Fujii; Hiroko Takagi; Isao Shibuya; Daisuke Oka; Naomitsu Yamaya; Hiraku Hagita; Makoto Matsumoto; Katsuya Inagaki
Journal:  Dig Dis Sci       Date:  2021-08-31       Impact factor: 3.487

Review 6.  Small Bowel Lesions Mimicking Crohn's Disease.

Authors:  David B Sachar
Journal:  Curr Gastroenterol Rep       Date:  2018-08-06

Review 7.  Practice Guidelines for Clinical Microbiology Laboratories: Mycobacteria.

Authors:  Betty A Forbes; Geraldine S Hall; Melissa B Miller; Susan M Novak; Marie-Claire Rowlinson; Max Salfinger; Akos Somoskövi; David M Warshauer; Michael L Wilson
Journal:  Clin Microbiol Rev       Date:  2018-01-31       Impact factor: 26.132

Review 8.  MAP, Johne's disease and the microbiome; current knowledge and future considerations.

Authors:  Chloe Matthews; Paul D Cotter; Jim O' Mahony
Journal:  Anim Microbiome       Date:  2021-05-07

Review 9.  Microbiome characterization and re-design by biologic agents for inflammatory bowel disease insights.

Authors:  Wenshuo Chen; Haijin Chen; Shudan Fu; Xiaohua Lin; Zheng Zheng; Jinlong Zhang
Journal:  Bioprocess Biosyst Eng       Date:  2020-05-26       Impact factor: 3.210

10.  Revealing immune responses in the Mycobacterium avium subsp. paratuberculosis-infected THP-1 cells using single cell RNA-sequencing.

Authors:  Hong-Tae Park; Woo Bin Park; Suji Kim; Jong-Sung Lim; Gyoungju Nah; Han Sang Yoo
Journal:  PLoS One       Date:  2021-07-02       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.